A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This trial is a multi-center, randomized, double-blind, placebo-controlled parallel group,
Phase 2 study in subjects with Type 2 diabetes mellitus on a stable dose of metformin to
evaluate the safety and efficacy of TTP273 versus placebo glucose control and body weight
following administration for 3 months.